Bravo, bravo for that.

We welcome your commentary on these two studies that essentially dispute what you have just said.

But, Doctor, isn't that true of any clinical trial? Some get the treatment, and some do not; some get the diagnosis, and some do not.

the only thing that we have is the breast and cervical screening program at CDC, which the women of Congress initiated.

Women don't know who to believe or what they should do--do they get a mammogram or not?

This year Congress must reauthorize the Mammography Quality Standards Act, because women must continue to have safe, quality mammograms.

For more than 20 years in the House and the Senate, we have been paired up as advocates in terms of helping not only to race for the cure but to race for every other tool we had to be able to find a cure and for prevention.

This is not just an issue for women in their 40's or 50's, but for women who are in their 20's and 30's.

Thank you very much, Madam Chairman, first for having this hearing, which I think is so important today.

I hope we do not lose our focus on that issue.

I am very worried that the current conflicting and confusing messages are not going to help our efforts to expand access.

I simply want to commend you for taking the initiative along with Senator Harkin on this very important issue

We must always be concerned about those, Senator Clinton, prevention and cure.

I want to help patients--that is why we are in medicine, to help patients--and I do not get enough to pay the expense in my office.

I am concerned, but not surprised, that this controversy has arisen again.

I want to commend you for holding this timely hearing on the quality of mammography screening.

I think that the National Breast Cancer Coalition's constant advocacy on behalf of more resources and better access has been an extremely important part of this debate.

I could not agree more with the point that Fran Visco made about the inequitable distribution of resources with respect to dealing with breast cancer.